abstract |
The present application relates to novel heterocyclic compounds of the general formula (I) and salts thereof, preferably pharmaceutically acceptable salts thereof, wherein R, R 1 , R 2 , R 3 , Q, m, and n are specified And the use of these compounds as medicaments, in particular as aldosterone synthase inhibitors. |